ID UKF-NB-3 AC CVCL_9904 SY UKF-NB3 DR IARC_TP53; 26506 DR Wikidata; Q54990311 RX CelloPub=CLPUB00123; RX PubMed=8949988; RX PubMed=9201287; RX PubMed=16142320; RX PubMed=16151587; RX PubMed=17505515; RX PubMed=19147553; RX PubMed=22170099; RX PubMed=22476102; RX PubMed=24466371; RX PubMed=25749379; RX PubMed=27517323; RX PubMed=27735941; RX PubMed=31581737; CC Doubling time: 22 +- 1.9 hours (PubMed=16142320); 26.6 +- 8.2 hours (PubMed=27517323). CC Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. ST Source(s): PubMed=31581737 ST Amelogenin: X ST CSF1PO: 10,11 ST D13S317: 11 ST D16S539: 13 ST D18S51: 16,18 ST D19S433: 14 ST D21S11: 29,33.2 ST D2S1338: 16,21 ST D3S1358: 15,18 ST D5S818: 11 ST D7S820: 10,11 ST D8S1179: 9,10 ST FGA: 19,25 ST Penta D: 8,15 ST Penta E: 12 ST TH01: 9,9.3 ST TPOX: 8 ST vWA: 15,18 DI NCIt; C3270; Neuroblastoma DI ORDO; Orphanet_635; Neuroblastoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female CA Cancer cell line DT Created: 06-06-12; Last updated: 27-11-25; Version: 15 CH CVCL_RT07 ! UKF-NB-3rBORTE20 CH CVCL_RT08 ! UKF-NB-3rCABAZI2 CH CVCL_RR89 ! UKF-NB-3rCARBO2000 CH CVCL_M478 ! UKF-NB-3rCDDP1000 CH CVCL_RQ61 ! UKF-NB-3rDACARB8 CH CVCL_RS03 ! UKF-NB-3rDOCE10 CH CVCL_RR90 ! UKF-NB-3rDOCE20 CH CVCL_9906 ! UKF-NB-3rDOX100 CH CVCL_RS04 ! UKF-NB-3rDOX20 CH CVCL_RR91 ! UKF-NB-3rETO100 CH CVCL_RT09 ! UKF-NB-3rETO200 CH CVCL_RQ62 ! UKF-NB-3rGEMCI10 CH CVCL_RT10 ! UKF-NB-3rGEMCI20 CH CVCL_RQ63 ! UKF-NB-3rIRINO800 CH CVCL_RS06 ! UKF-NB-3rMEL2000 CH CVCL_RQ64 ! UKF-NB-3rMEL400 CH CVCL_RS05 ! UKF-NB-3rNutlin10muM CH CVCL_RQ65 ! UKF-NB-3rOXALI2000 CH CVCL_RT11 ! UKF-NB-3rOXALI4000 CH CVCL_RQ66 ! UKF-NB-3rPCL20 CH CVCL_RS21 ! UKF-NB-3rRITA10muM CH CVCL_RS19 ! UKF-NB-3rSNS-032_300nM CH CVCL_RQ67 ! UKF-NB-3rTOPO15 CH CVCL_RT12 ! UKF-NB-3rTOPO20 CH CVCL_9905 ! UKF-NB-3rVCR10 CH CVCL_RS08 ! UKF-NB-3rVCR20 CH CVCL_RR82 ! UKF-NB-3rVINB10 CH CVCL_RQ68 ! UKF-NB-3rVINOR20 CH CVCL_RT24 ! UKF-NB-3rYM155_20nM // RX PubMed=24466371; DOI=10.1593/tlo.13544; PMCID=PMC3890703; RA Loschmann, Nadine RA Michaelis, Martin RA Rothweiler, Florian RA Zehner, Richard RA Cinatl, Jaroslaw RA Voges, Yvonne RA Sharifi, Mohsen RA Riecken, Kristoffer RA Meyer, Jochen RA von Deimling, Andreas RA Fichtner, Iduna RA Ghafourian, Taravat RA Westermann, Frank RA Cinatl, Jindrich Jr. RT "Testing of SNS-032 in a panel of human neuroblastoma cell lines with RT acquired resistance to a broad range of drugs."; RL Transl. Oncol. 6:685-696(2013). // RX PubMed=16142320; DOI=10.3892/ijo.27.4.1029; RA Kotchetkov, Rouslan RA Hernaiz Driever, Pablo RA Cinatl, Jaroslaw RA Michaelis, Martin RA Karaskova, Jana RA Blaheta, Roman A. RA Squire, Jeremy Andrew RA von Deimling, Andreas RA Moog, Jussi RA Cinatl, Jindrich Jr. RT "Increased malignant behavior in neuroblastoma cells with acquired RT multi-drug resistance does not depend on P-gp expression."; RL Int. J. Oncol. 27:1029-1037(2005). // RX PubMed=8949988; DOI=10.1097/00001813-199609000-00008; RA Cinatl, Jindrich Jr. RA Cinatl, Jaroslaw RA Scholz, Martin RA Hernaiz Driever, Pablo RA Henrich, Dirk RA Kabickova, Hanka RA Vogel, Jens-Uwe RA Doerr, Hans-Wilhelm RA Kornhuber, Bernhard RT "Antitumor activity of sodium valproate in cultures of human RT neuroblastoma cells."; RL Anticancer Drugs 7:766-773(1996). // RX PubMed=22170099; DOI=10.1038/cddis.2011.129; PMCID=PMC3252738; RA Michaelis, Martin RA Rothweiler, Florian RA Barth, Susanne RA Cinatl, Jaroslaw RA van Rikxoort, Marijke RA Loschmann, Nadine RA Voges, Yvonne RA Breitling, Rainer RA von Deimling, Andreas RA Rodel, Franz RA Weber, Kristoffer RA Fehse, Boris RA Mack, Elisabeth RA Stiewe, Thorsten RA Doerr, Hans-Wilhelm RA Speidel, Daniel RA Cinatl, Jindrich Jr. RT "Adaptation of cancer cells from different entities to the MDM2 RT inhibitor nutlin-3 results in the emergence of p53-mutated RT multi-drug-resistant cancer cells."; RL Cell Death Dis. 2:e243.1-e243.8(2011). // RX PubMed=25749379; DOI=10.18632/oncotarget.2889; PMCID=PMC4627332; RA Michaelis, Martin RA Rothweiler, Florian RA Loschmann, Nadine RA Sharifi, Mohsen RA Ghafourian, Taravat RA Cinatl, Jindrich Jr. RT "Enzastaurin inhibits ABCB1-mediated drug efflux independently of RT effects on protein kinase C signalling and the cellular p53 status."; RL Oncotarget 6:17605-17620(2015). // RX PubMed=27735941; DOI=10.1038/cddis.2016.257; PMCID=PMC5133961; RA Voges, Yvonne RA Michaelis, Martin RA Rothweiler, Florian RA Schaller, Torsten RA Schneider, Constanze RA Politt, Katharina RA Mernberger, Marco RA Nist, Andrea RA Stiewe, Thorsten RA Wass, Mark N. RA Rodel, Franz RA Cinatl, Jindrich Jr. RT "Effects of YM155 on survivin levels and viability in neuroblastoma RT cells with acquired drug resistance."; RL Cell Death Dis. 7:e2410.1-e2410.11(2016). // RX PubMed=9201287; RA Cinatl, Jindrich Jr. RA Hernaiz Driever, Pablo RA Cinatl, Jaroslaw RA Ruckert, Dieter G. RA Gumbel, Hermann O.C. RA Rabenau, Holger F. RA Kornhuber, Bernhard RA Doerr, Hans-Wilhelm RT "Increased efficacy of aphidicolin killing of human neuroblastoma RT cells in vitro by encapsulation in liposomes."; RL Neoplasma 44:91-95(1997). // RX PubMed=27517323; DOI=10.18632/oncotarget.11160; PMCID=PMC5295411; RA Loschmann, Nadine RA Michaelis, Martin RA Rothweiler, Florian RA Voges, Yvonne RA Balonova, Barbora RA Blight, Barry A. RA Cinatl, Jindrich Jr. RT "ABCB1 as predominant resistance mechanism in cells with acquired RT SNS-032 resistance."; RL Oncotarget 7:58051-58064(2016). // RX PubMed=16151587; RA Bedrnicek, Jiri B. RA Vicha, Ales RA Jarosova, Marie RA Holzerova, Milena RA Cinatl, Jindrich Jr. RA Michaelis, Martin RA Cinatl, Jaroslaw RA Eckschlager, Tomas RT "Characterization of drug-resistant neuroblastoma cell lines by RT comparative genomic hybridization."; RL Neoplasma 52:415-419(2005). // RX CelloPub=CLPUB00123; RA Cinatl, Jaroslaw RA Gussetis, Evgenios S. RA Cinatl, Jindrich Jr. RA Ebener, Uwe RA Mainke, Marion RA Schwabe, Dirk RA Doerr, Hans-Wilhelm RA Kornhuber, Bernhard RA Gerein, Valentin RT "Differentiation arrest in neuroblastoma cell culture."; RL J. Cancer Res. Clin. Oncol. 116 Suppl. 1:9-9(1990). // RX PubMed=17505515; DOI=10.1038/sj.bjc.6603777; PMCID=PMC2359931; RA Blaheta, Roman A. RA Michaelis, Martin RA Natsheh, Iyad RA Hasenberg, Christoph RA Weich, Eva RA Relja, Borna RA Jonas, Dietger RA Doerr, Hans-Wilhelm RA Cinatl, Jindrich Jr. RT "Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant RT neuroblastoma tumour cells to endothelium."; RL Br. J. Cancer 96:1699-1706(2007). // RX PubMed=19147553; DOI=10.1158/0008-5472.CAN-08-1856; RA Michaelis, Martin RA Rothweiler, Florian RA Klassert, Denise RA von Deimling, Andreas RA Weber, Kristoffer RA Fehse, Boris RA Kammerer, Bernd RA Doerr, Hans-Wilhelm RA Cinatl, Jindrich Jr. RT "Reversal of P-glycoprotein-mediated multidrug resistance by the RT murine double minute 2 antagonist nutlin-3."; RL Cancer Res. 69:416-421(2009). // RX PubMed=31581737; DOI=10.3390/cells8101194; PMCID=PMC6830094; RA Povey, Jane F. RA Saintas, Emily RA Aderemi, Adewale Victor RA Rothweiler, Florian RA Zehner, Richard RA Dirks, Wilhelm Gerhard RA Cinatl, Jindrich Jr. RA Racher, Andrew J. RA Wass, Mark N. RA Smales, Christopher Mark RA Michaelis, Martin RT "Intact-cell MALDI-ToF mass spectrometry for the authentication of RT drug-adapted cancer cell lines."; RL Cells 8:1194.1-1194.12(2019). // RX PubMed=22476102; DOI=10.1038/cddis.2012.35; PMCID=PMC3358013; RA Michaelis, Martin RA Rothweiler, Florian RA Agha, Bishr RA Barth, Susanne RA Voges, Yvonne RA Loschmann, Nadine RA von Deimling, Andreas RA Breitling, Rainer RA Doerr, Hans-Wilhelm RA Rodel, Franz RA Speidel, Daniel RA Cinatl, Jindrich Jr. RT "Human neuroblastoma cells with acquired resistance to the p53 RT activator RITA retain functional p53 and sensitivity to other p53 RT activating agents."; RL Cell Death Dis. 3:e294.1-e294.8(2012). //